Evaluations of unformulated and formulated dendrimer-based microbicide candidates in mouse and guinea pig models of genital herpes
- PMID: 14638483
- PMCID: PMC296200
- DOI: 10.1128/AAC.47.12.3784-3788.2003
Evaluations of unformulated and formulated dendrimer-based microbicide candidates in mouse and guinea pig models of genital herpes
Abstract
Prevention of sexually transmitted infections is a priority in developed and developing countries. One approach to prevention is the use of topical microbicides, and one promising approach is the use of dendrimers, highly branched macromolecules synthesized from a polyfunctional core. Three new dendrimer products developed to provide stable and cost-efficient microbicides were initially evaluated in vitro for anti-herpes simplex virus activity and then in vivo by using a mouse model of genital herpes. From these experiments one product, SPL7013, was chosen for further evaluation to define the dose and duration of protection. Unformulated SPL7013 provided significant protection from genital herpes disease and infection at concentrations as low as 1 mg/ml and for at least 1 h following topical (intravaginal) administration of 10 mg/ml. This compound was then formulated into three vehicles and further evaluated in mouse and guinea pig models of genital herpes infection. In the murine evaluations each of the formulations provided significant protection at concentrations of 10 and 50 mg/ml. Formulated compounds provided protection for at least 1 h at a concentration of 10 mg/ml. From these experiments formulation 2V was chosen for dose ranging experiments using the guinea pig model of genital herpes. The guinea pig evaluations suggested that doses of 30 to 50 mg/ml were required for optimal protection. From these studies a lead compound and formulation (2V of SPL7013) was chosen for ongoing evaluations in primate models of simian immunodeficiency virus and Chlamydia trachomatis infection.
Figures

Similar articles
-
Plant products as topical microbicide candidates: assessment of in vitro and in vivo activity against herpes simplex virus type 2.Antiviral Res. 1999 Jul;42(3):219-26. doi: 10.1016/s0166-3542(99)00020-0. Antiviral Res. 1999. PMID: 10443534
-
Dendrimers, a new class of candidate topical microbicides with activity against herpes simplex virus infection.Antimicrob Agents Chemother. 2000 Sep;44(9):2471-4. doi: 10.1128/AAC.44.9.2471-2474.2000. Antimicrob Agents Chemother. 2000. PMID: 10952597 Free PMC article.
-
Preclinical safety and efficacy assessments of dendrimer-based (SPL7013) microbicide gel formulations in a nonhuman primate model.Antimicrob Agents Chemother. 2006 May;50(5):1696-700. doi: 10.1128/AAC.50.5.1696-1700.2006. Antimicrob Agents Chemother. 2006. PMID: 16641437 Free PMC article.
-
Use of the Guinea pig model of genital herpes to evaluate vaccines and antivirals: Review.Antiviral Res. 2020 Aug;180:104821. doi: 10.1016/j.antiviral.2020.104821. Epub 2020 Jun 13. Antiviral Res. 2020. PMID: 32544409 Free PMC article. Review.
-
Mechanistic Studies of Viral Entry: An Overview of Dendrimer-Based Microbicides As Entry Inhibitors Against Both HIV and HSV-2 Overlapped Infections.Med Res Rev. 2017 Jan;37(1):149-179. doi: 10.1002/med.21405. Epub 2016 Aug 12. Med Res Rev. 2017. PMID: 27518199 Review.
Cited by
-
Dendrimers as tunable vectors of drug delivery systems and biomedical and ocular applications.Int J Nanomedicine. 2015 Dec 22;11:1-12. doi: 10.2147/IJN.S93069. eCollection 2016. Int J Nanomedicine. 2015. PMID: 26730187 Free PMC article. Review.
-
Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel) in sexually active young women (MTN-004).AIDS. 2011 May 15;25(8):1057-64. doi: 10.1097/QAD.0b013e328346bd3e. AIDS. 2011. PMID: 21505316 Free PMC article. Clinical Trial.
-
A potent combination microbicide that targets SHIV-RT, HSV-2 and HPV.PLoS One. 2014 Apr 16;9(4):e94547. doi: 10.1371/journal.pone.0094547. eCollection 2014. PLoS One. 2014. PMID: 24740100 Free PMC article.
-
Astodrimer sodium nasal spray forms a barrier to SARS-CoV-2 in vitro and preserves normal mucociliary function in human nasal epithelium.Sci Rep. 2024 Sep 11;14(1):21259. doi: 10.1038/s41598-024-72262-w. Sci Rep. 2024. PMID: 39261670 Free PMC article.
-
Structure activity relationship of dendrimer microbicides with dual action antiviral activity.PLoS One. 2010 Aug 23;5(8):e12309. doi: 10.1371/journal.pone.0012309. PLoS One. 2010. PMID: 20808791 Free PMC article.
References
-
- Bourne, N., D. I. Bernstein, J. Ireland, A. J. Sonderfan, A. T. Profy, and L. R. Stanberry. 1999. The topical microbicide PRO 2000 protects against genital herpes infection in a mouse model. J. Infect. Dis. 180:203-205. - PubMed
-
- Bourne, N., J. Ireland, L. R. Stanberry, and D. I. Bernstein. 1999. Effect of undecylenic acid as a topical microbicide against genital herpes infection in mice and guinea pigs. Antivir. Res. 40:139-144. - PubMed
-
- Fisman, D. N., M. Lipsitch, E. W. Hook III, and S. J. Goldie. 2002. Projection of the future dimensions and costs of the genital herpes simplex type 2 epidemic in the United States. Sex. Transm. Dis. 29:608-622. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical